Actions - Biotech
Retour à la Hiérarchie des Classes d'Actions
Rang Tech. | Actions | Cours | Synthèse Technique | Momentums | Accé- léra- tion | Tac- tique | ROBO Analyse | Secteurs | PER (X) | Rendt (%) | Croiss. BPA | Croiss. CFA | Croiss. BKV | Croiss. Ventes | Marge Nette | Rentab. Cap.Inv | Dettes ebitda | Tickers | Capi. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Absolu | Relatif | |||||||||||||||||||
46 | Swed. Orphan Bio | 217.7 | +++ | Neutre | +++ | + | ++ | Biotech | 19.7 X | 0.0% | Neutre | + | +++++ | +++ | +++ | Neutre | + | SOBI | MID | |
42 | Taux = + 10% | +++ | ++ | +++ | ||||||||||||||||
37 | Pluvalca Health Opport. A | 109.7 | ++ | + | +++ | Neutre | + | 2.10 | Small | |||||||||||
24 | Taux = + 5% | + | + | ++ | ||||||||||||||||
18 | Vilmorin | 63.80 | + | + | ++ | Neutre | * | Biotech | 12.1 X | 2.6% | +++ | + | ++ | +++ | - - | - - - - | - - - | RIN | Small | |
16 | Tx ESTER j/j rate | + | + | + | ||||||||||||||||
11 | Franklin Biotech Discovery A | 33.50 | + | Neutre | Neutre | Neutre | + | Small | ||||||||||||
0 | Taux ZERO | Neutre | Neutre | Neutre | ||||||||||||||||
0 | Genmab A/S | 2 604 | Neutre | - | - | Neutre | + | Biotech | 30.0 X | 0.0% | + | +++ | +++++ | +++++ | +++++ | ++++ | +++++ | GMA | BIG | |
-11 | Candriam Eqties. L Biotech C | 754.2 | - | - | - - | Neutre | + | BIG | ||||||||||||
-21 | Taux = - 5% | - | - | - - | ||||||||||||||||
-67 | Chr. Hansen | 444.6 | - - - - | - - - | - - - - - | Neutre | Biotech | 32.2 X | 1.7% | +++ | +++ | ++ | + | +++ | + | Neutre | CHR | MID | ||
-85 | CS L Digital Health Eqt. B | 585.4 | - - - - - | - - - | - - - - - | - | BIG |